30 Participants Needed

Coping and Communication Skills Training for Gynecologic Cancers

SL
Overseen BySharon L Manne, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Rutgers, The State University of New Jersey
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Journey Ahead for gynecologic cancers?

Research shows that effective communication and coping skills can improve emotional well-being and reduce distress in women with gynecologic cancers. These skills help patients process emotions better, build trust with healthcare providers, and make informed decisions about their care.12345

How is the treatment Journey Ahead different from other treatments for gynecologic cancers?

Journey Ahead is unique because it focuses on coping and communication skills training, helping women with gynecologic cancers process their emotions and improve their communication, which is different from standard medical treatments that primarily address physical symptoms.16789

What is the purpose of this trial?

This trial tests the Journey Ahead online program, which helps people with gynecologic cancers improve their coping and communication skills. The program includes educational content and activities to reduce stress and enhance emotional management. Researchers will gather feedback from participants and assess the program's effectiveness.

Research Team

SL

Sharon L Manne, PhD

Principal Investigator

Rutgers Cancer Institute of New Jersey

Eligibility Criteria

This trial is for women over 18 who've been diagnosed with various gynecological cancers, including uterine, ovarian, and cervical cancer. Participants should be within 5 years post-cancer surgery or treatment like chemo or radiation and must have internet access to view online sessions.

Inclusion Criteria

I was diagnosed with Stage 2 or higher cervical cancer or had a recurrence in the last 5 years.
I can access the internet and participate in online sessions and telehealth chats.
I am mostly active and can carry out my daily activities.
See 6 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants engage in the Journey Ahead intervention focusing on coping and communication skill development during the course of 8 sessions and 6 phone calls.

8 weeks

Follow-up

Participants are monitored for changes in distress, coping, and other psychological measures post-intervention.

6 months

Treatment Details

Interventions

  • Journey Ahead
Trial Overview The 'Journey Ahead' intervention is being tested to see if it helps improve coping and communication skills in women with gynecologic cancers. It involves informational sessions viewed online followed by discussions via phone or video chat.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Journey AheadExperimental Treatment2 Interventions
Experimental: Journey Ahead intervention focusing on coping and communication skill development during the course of 8 sessions and 6 phone calls.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rutgers, The State University of New Jersey

Lead Sponsor

Trials
471
Recruited
81,700+

Findings from Research

Women newly diagnosed with gynecological cancer showed the ability to engage in emotional processing during therapy sessions, with average ratings indicating they discussed their feelings and experiences meaningfully.
In the coping and communication skills intervention (CCI), higher levels of emotional processing were linked to greater perceived progress in therapy, suggesting that this emotional engagement may enhance treatment outcomes for patients.
Emotional processing during psychotherapy among women newly diagnosed with a gynecological cancer.Manne, SL., Myers-Virtue, S., Darabos, K., et al.[2022]
The coping and communication-enhancing intervention (CCI) significantly reduced depressive symptoms and cancer-specific distress in 352 women with gynecological cancer over the first six months compared to supportive counseling (SC) and usual care (UC).
Unlike SC, which showed no significant benefits, CCI improved emotional well-being and demonstrated that structured psychological interventions are essential for effectively addressing distress in newly diagnosed cancer patients.
A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients.Manne, SL., Virtue, SM., Ozga, M., et al.[2018]
Effective communication between gynecologic oncology providers and patients is essential for improving patient knowledge, trust, and shared decision-making, which ultimately leads to better patient-centered care.
Training in serious illness communication skills is crucial for healthcare providers, as it not only enhances patient outcomes but also reduces provider burnout by equipping them to handle emotionally charged situations more effectively.
Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide.Littell, RD., Kumar, A., Einstein, MH., et al.[2019]

References

Emotional processing during psychotherapy among women newly diagnosed with a gynecological cancer. [2022]
A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients. [2018]
Advanced communication: A critical component of high quality gynecologic cancer care: A Society of Gynecologic Oncology evidence based review and guide. [2019]
Coping and quality of life in Turkish women living with ovarian cancer. [2022]
How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis. [2020]
Coping with cancer: examining the supports available to women with gynecologic cancer at Saskatoon Cancer Center. [2018]
[Associations Between Stress Coping Strategies and Perceived Social Support in Young Patients with Gynecologic Cancers]. [2018]
Dyadic coping in young and middle-aged women with gynecological cancer: a latent class analysis. [2022]
Care Processes and Quality-of-Life Outcomes Affecting the Gynecologic Cancer Survivorship Experience. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security